New hope for tough cervical cancer: experimental drug trial
NCT ID NCT05063916
Summary
This study is testing an experimental immunotherapy drug called AK104 for women with a rare, aggressive form of cervical cancer that has returned or spread after prior chemotherapy. The main goal is to see if the drug can keep the cancer from growing for at least 6 months. Researchers will also closely monitor side effects and see if a blood test can help track how well the treatment is working.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.